Saykara Launches First Fully Ambient AI Healthcare Voice Assistant


Saykara today announced the release of Kara 2.0, an AI-powered healthcare assistant that further simplifies the documentation process for physicians. Now featuring Ambient Mode, Kara 2.0 is a breakthrough AI-powered voice application for healthcare, allowing physicians and patients to interact as they normally do, all while Saykara listens, transcribes to text, parses text into structured data, and intelligently completes each form in a patient's electronic health record (EHR or chart). Saykara then automatically generates a clinic note including patient history, physical, assessment, plan, orders and referrals. With the release of Ambient Mode, Saykara is the only virtual healthcare assistant that can be used passively'in the room' during physician-patient appointments with no voice commands. Ambient Mode builds on Saykara's versatility and agnosticity, allowing it to better serve up to 18 disparate healthcare specialties, including primary care, pediatrics, internal medicine, orthopedics, urology and more.

AI is integral to the future of healthcare -- but for now, so are humans


Artificial intelligence has been around for half a century, but it has only recently become a real player in the healthcare space. Harjinder Sandhu, the CEO and founder of SayKara, says that's all down to data. "The data never really existed" for AI to take off, Sandhu said on a panel about AI and the future of healthcare at the 2018 GeekWire Summit. "In healthcare specifically, if you look back 20 years, virtually every medical record was on paper." Sandhu was joined on stage by Michael Calhoun, CEO and co-founder of medical imaging analysis company Mindshare Medical, and Anisha Sood, a partner at Echo Health Ventures.

AI startup AntWorks raises $15 mln from Japanese VC


AntWorks, a provider of artificial intelligence (AI) and automation products and solutions, on Monday said that it has raised $15 million from Japanese venture capital firm SBI Investment in a series A funding round. The company did not disclose the valuation of the deal and other transactional details. The Singapore-headquartered company pointed out that the funding will be utilised to fuel its growth plans across product offerings, strengthening its research and development (R&D) base, ramping up its marketing and sales channel, and foraying into newer markets. SBI Investment, a subsidiary of financial-services company SBI Holdings, will also form a joint venture with AntWorks to expand its base and tap into the emerging AI market in South-East Asia. AntWorks was founded by former vice-president and head of Infosys BPO for Asia Pacific, Asheesh Mehra along with Govind Sandhu in 2015.

Woman shocked to find dead rodent in spinach salad: 'I felt like vomiting'

FOX News

A woman was horrified by what her spinach salad contained. Sukhdeep Sandhu was shopping for groceries at a discount supermarket chain, Spudshed, in Perth, Australia, with her 9-year-old daughter when she picked up a bag of baby spinach and made a shocking discovery. "I was just about to put the [1 pound] bag in my trolley when I saw the dead mouse or rat in the package," she told Fairfax news. AMERICA'S FAVORITE VEGETABLE IS BROCCOLI, SURVEY SAYS "I felt like vomiting," she continued. Sandhu told the news outlet she spoke to the grocery store supervisor about the alarming find, and they immediately ordered staff to remove the remaining bags of lettuce from the shelves.

Chinu Sandhu: Four-year drugs ban for Commonwealth Games medallist

BBC News

British wrestler Chinu Sandhu, who won Commonwealth bronze in 2014, has been banned for four years after failing an out-of-competition drugs test. Sandhu, 29, who competed in the 125kg men's freestyle, tested positive for an anabolic steroid in September. "It is sad that his reputation within the sport has been tainted because of his own actions," UK Anti-Doping chief executive Nicole Sapstead said. British Wrestling said the news was "extremely disappointing". A BBC State of Sport investigation into doping in amateur sport led to UK Anti-Doping (Ukad) saying drug use at every level of sport is "fast becoming a crisis".